Svetlana Lorenzano1, Niaz Ahmed, Turgut Tatlisumak, Meritxell Gomis, Antoni Dávalos, Robert Mikulik, Petr Sevcik, Jyrki Ollikainen, Nils Wahlgren, Danilo Toni. 1. From the Emergency Department Stroke Unit, Department of Neurology and Psychiatry, Policlinico Umberto I Hospital, Sapienza University of Rome, Rome, Italy (S.L., D.T.); Karolinska Stroke Research Unit, Department of Neurology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden (N.A., N.W.); Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland (T.T.); Acute Stroke Unit, Department of Neuroscience, Hospital Universitari Germas Trias i Pujol, Universidad Autònoma de Barcelona, Barcelona, Spain (M.G., A.D.); International Clinical Research Center, Neurology Department, St. Anne's Hospital, Brno, Czech Republic (R.M.); Department of Neurology, University Hospital, Plzen, Czech Republic (P.S.); and Department of Neurology and Rehabilitation, Tampere University Hospital, Tampere, Finland (J.O.).
Abstract
BACKGROUND AND PURPOSE: Temporal variations of thrombolysis delivery and their influence on outcome have been reported with controversial results. In this large cohort study, we evaluated whether thrombolytic treatment has a within-day and weekly variability corresponding to circadian and weekly patterns of ischemic stroke onset, and whether these have impact on clinical outcome. METHODS: We retrospectively analyzed patients with acute ischemic stroke receiving intravenous alteplase, prospectively included in the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register. Patients were grouped by treatment on day hours (08:00-19:59) or night hours (20:00-07:59) and treatment on weekdays and weekends. For each subgroup, we analyzed frequency of thrombolytic treatments, time intervals, and outcomes (3-month modified Rankin Scale score 0-2 as good functional outcome, mortality, symptomatic intracerebral hemorrhage). RESULTS: We included 21 513 patients. Considering the mean expected number of patients treated per hour (0.4) and per day of the week (9.8), if no temporal variations were present, patients were significantly treated more during day hours and weekdays (P<0.0001). Median door-to-needle and onset-to-treatment times were longer for patients treated during night hours and on weekends (P<0.01). After adjustment for confounding variables, treatment during day hours was an independent predictor of good functional outcome (odds ratio, 1.12; 95% confidence interval, 1.04-1.21; P=0.004), and patients treated during weekdays were at risk of higher mortality (odds ratio, 1.15; 95% confidence interval, 1.04-1.28; P=0.008). CONCLUSIONS: Frequency of thrombolytic treatment seems to follow the same circadian pattern of stroke incidence, whereas its correspondence to a weekly pattern is less clear. Time of treatment is an independent predictor of outcome.
BACKGROUND AND PURPOSE: Temporal variations of thrombolysis delivery and their influence on outcome have been reported with controversial results. In this large cohort study, we evaluated whether thrombolytic treatment has a within-day and weekly variability corresponding to circadian and weekly patterns of ischemic stroke onset, and whether these have impact on clinical outcome. METHODS: We retrospectively analyzed patients with acute ischemic stroke receiving intravenous alteplase, prospectively included in the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register. Patients were grouped by treatment on day hours (08:00-19:59) or night hours (20:00-07:59) and treatment on weekdays and weekends. For each subgroup, we analyzed frequency of thrombolytic treatments, time intervals, and outcomes (3-month modified Rankin Scale score 0-2 as good functional outcome, mortality, symptomatic intracerebral hemorrhage). RESULTS: We included 21 513 patients. Considering the mean expected number of patients treated per hour (0.4) and per day of the week (9.8), if no temporal variations were present, patients were significantly treated more during day hours and weekdays (P<0.0001). Median door-to-needle and onset-to-treatment times were longer for patients treated during night hours and on weekends (P<0.01). After adjustment for confounding variables, treatment during day hours was an independent predictor of good functional outcome (odds ratio, 1.12; 95% confidence interval, 1.04-1.21; P=0.004), and patients treated during weekdays were at risk of higher mortality (odds ratio, 1.15; 95% confidence interval, 1.04-1.28; P=0.008). CONCLUSIONS: Frequency of thrombolytic treatment seems to follow the same circadian pattern of stroke incidence, whereas its correspondence to a weekly pattern is less clear. Time of treatment is an independent predictor of outcome.
Authors: Steffen Tiedt; Alastair M Buchan; Martin Dichgans; Ignacio Lizasoain; Maria A Moro; Eng H Lo Journal: Nat Rev Neurol Date: 2022-09-09 Impact factor: 44.711
Authors: Björn Reuter; Tamara Sauer; Christoph Gumbinger; Ingo Bruder; Stella Preussler; Werner Hacke; Michael G Hennerici; Peter A Ringleb; Rolf Kern; Christian Stock Journal: Front Neurol Date: 2017-07-21 Impact factor: 4.003
Authors: Christopher I Price; Lisa Shaw; Peter Dodd; Catherine Exley; Darren Flynn; Richard Francis; Saiful Islam; Mehdi Javanbakht; Rachel Lakey; Joanne Lally; Graham McClelland; Peter McMeekin; Helen Rodgers; Helen Snooks; Louise Sutcliffe; Pippa Tyrell; Luke Vale; Alan Watkins; Gary A Ford Journal: Trials Date: 2019-02-12 Impact factor: 2.279
Authors: Christopher I Price; Lisa Shaw; Saiful Islam; Mehdi Javanbakht; Alan Watkins; Peter McMeekin; Helen Snooks; Darren Flynn; Richard Francis; Rachel Lakey; Lou Sutcliffe; Graham McClelland; Joanne Lally; Catherine Exley; Helen Rodgers; Ian Russell; Luke Vale; Gary A Ford Journal: JAMA Neurol Date: 2020-07-01 Impact factor: 18.302